Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors
L E Perez; H Fernandez; E Ayala; F Beato; A Neuger; J Pidala; M J Schell; C Anasetti
Author Information: Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.